E-slide Library

Assessment of disease in IBD: Endoscopy and beyond

Philippe Marteau, MD, PhD

Professor of Gastroenterology
University Denis Diderot Paris Cité
Chief of the Gastroenterology Department
Lariboisière Hospital
Paris, France

Biography



Introduction

Gastrointestinal (GI) endoscopy has a pivotal role in the diagnosis of suspected inflammatory bowel disease (IBD). Beyond its diagnostic utility, GI endoscopy has an important role in the staging of severity of disease, evaluation and treatment of strictures, detection of postoperative recurrence, assessment of the efficacy of medical therapy, surveillance for neoplasms, and preoperative assessment, particularly in Crohn's disease.

This hot topic will review the diagnostic accuracy of GI endoscopy, the major endoscopic findings that may be seen in patients with IBD, and some practical considerations regarding endoscopy in patients with suspected IBD. We will also discuss when to use other diagnostic modalities either in combination with, or instead of, endoscopy.

This activity has been designed to meet the educational needs of gastroenterologists and registered nurses involved in the care of patients with inflammatory bowel disease (IBD).

Release date: April 30, 2015

Learning objectives

After completing this activity, the participant should be better able to:

  • Evaluate the role of endoscopy in assessing IBD
  • Describe the prognostic value of (some) lesions in ulcerative colitis and Crohn's disease
  • Summarize the systems used to grade the severity of lesions in ulcerative colitis and Crohn's disease
  • Assess the severity of lesions in patients who had ileal resection for Crohn's disease and adapt treatment accordingly
  • Provide appropriate care and counsel for patients and their families.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

View Presentation